Last 12 months
Inside the activity.
2 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 24,876 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · nonDerivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · derivative · entry 8 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,205 Underlying: Common Stock · 3,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Tax withholdingCommon Stock | 1,190 | $33.36 | $39,698.40 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · nonDerivative · entry 4 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,931 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionCommon Stock | 3,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · nonDerivative · entry 3 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
VOPNI SCOTT KChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000017 · wf-form4_164513515094090.xml · derivative · entry 4 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,383 Underlying: Common Stock · 2,423 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
VOPNI SCOTT KChief Accounting Officer
|
Tax withholdingCommon Stock | 1,020 | $33.36 | $34,027.20 |
DisclosureSEC source: 0000030625-22-000017 · wf-form4_164513515094090.xml · nonDerivative · entry 2 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
VOPNI SCOTT KChief Accounting Officer
|
Exercise / conversionCommon Stock | 2,478 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000017 · wf-form4_164513515094090.xml · nonDerivative · entry 1 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Schwetz Amy BChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000020 · wf-form4_164513523798128.xml · derivative · entry 5 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,219 Underlying: Common Stock · 6,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Schwetz Amy BChief Financial Officer
|
Tax withholdingCommon Stock | 2,736 | $33.36 | $91,272.96 |
DisclosureSEC source: 0000030625-22-000020 · wf-form4_164513523798128.xml · nonDerivative · entry 2 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,027 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:01 UTC |
Schwetz Amy BChief Financial Officer
|
Exercise / conversionCommon Stock | 7,010 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000020 · wf-form4_164513523798128.xml · nonDerivative · entry 1 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · derivative · entry 8 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,676 Underlying: Common Stock · 3,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 1,192 | $33.36 | $39,765.12 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · nonDerivative · entry 4 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,236 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 3,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · nonDerivative · entry 3 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,653 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · derivative · entry 8 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,035 Underlying: Common Stock · 2,653 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Tax withholdingCommon Stock | 650 | $33.36 | $21,684.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · nonDerivative · entry 4 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,858 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionCommon Stock | 2,713 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · nonDerivative · entry 3 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:58 UTC |
Morytko TamaraPresident, FPD
|
Exercise / conversionRestricted Stock Units · Derivative | 3,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000015 · wf-form4_164513507166994.xml · derivative · entry 5 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,534 Underlying: Common Stock · 3,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:58 UTC |
Morytko TamaraPresident, FPD
|
Tax withholdingCommon Stock | 1,254 | $33.36 | $41,833.44 |
DisclosureSEC source: 0000030625-22-000015 · wf-form4_164513507166994.xml · nonDerivative · entry 2 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,912 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:58 UTC |
Morytko TamaraPresident, FPD
|
Exercise / conversionCommon Stock | 3,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000015 · wf-form4_164513507166994.xml · nonDerivative · entry 1 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:57 UTC |
Wilson KirkPresident, FCD
|
Exercise / conversionRestricted Stock Units · Derivative | 2,572 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000014 · wf-form4_164513503653760.xml · derivative · entry 8 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,190 Underlying: Common Stock · 2,572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:57 UTC |
Wilson KirkPresident, FCD
|
Tax withholdingCommon Stock | 579 | $33.36 | $19,315.44 |
DisclosureSEC source: 0000030625-22-000014 · wf-form4_164513503653760.xml · nonDerivative · entry 4 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,894 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:57 UTC |
Wilson KirkPresident, FCD
|
Exercise / conversionCommon Stock | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000014 · wf-form4_164513503653760.xml · nonDerivative · entry 3 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionPerformance Rights · Derivative | 65,680 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · derivative · entry 7 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,343 Underlying: Common Stock · 65,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantPerformance Rights · Derivative | 87,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · derivative · entry 6 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,023 Underlying: Common Stock · 87,893 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 87,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · derivative · entry 5 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,277 Underlying: Common Stock · 87,893 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
Tax withholdingCommon Stock | 10,638 | $32.62 | $347,011.56 |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,863 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:02 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 23,414 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-22-000022 · wf-form4_164513532667564.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionPerformance Rights · Derivative | 8,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · derivative · entry 7 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,870 Underlying: Common Stock · 8,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
GrantPerformance Rights · Derivative | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · derivative · entry 6 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,230 Underlying: Common Stock · 10,700 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · derivative · entry 5 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,301 Underlying: Common Stock · 10,700 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Tax withholdingCommon Stock | 1,234 | $32.62 | $40,253.08 |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · nonDerivative · entry 2 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,955 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burger ElizabethChief Human Resources Officer
|
Exercise / conversionCommon Stock | 2,981 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-22-000021 · wf-form4_164513529104198.xml · nonDerivative · entry 1 Burger Elizabeth · CIK 0001582071 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
VOPNI SCOTT KChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 8,536 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000017 · wf-form4_164513515094090.xml · derivative · entry 3 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 8,536 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Schwetz Amy BChief Financial Officer
|
GrantPerformance Rights · Derivative | 25,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000020 · wf-form4_164513523798128.xml · derivative · entry 4 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,081 Underlying: Common Stock · 25,221 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Schwetz Amy BChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 25,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000020 · wf-form4_164513523798128.xml · derivative · entry 3 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,075 Underlying: Common Stock · 25,221 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Duhon Lamar L.President, AMSS
|
GrantPerformance Rights · Derivative | 8,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000018 · wf-form4_164513519451084.xml · derivative · entry 2 Duhon Lamar L. · CIK 0001904002 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Underlying: Common Stock · 8,025 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Duhon Lamar L.President, AMSS
|
GrantRestricted Stock Units · Derivative | 8,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000018 · wf-form4_164513519451084.xml · derivative · entry 1 Duhon Lamar L. · CIK 0001904002 · President, AMSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Underlying: Common Stock · 8,025 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionPerformance Rights · Derivative | 7,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · derivative · entry 7 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,348 Underlying: Common Stock · 7,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
GrantPerformance Rights · Derivative | 12,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · derivative · entry 6 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,518 Underlying: Common Stock · 12,228 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
GrantRestricted Stock Units · Derivative | 12,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · derivative · entry 5 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,772 Underlying: Common Stock · 12,228 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 1,067 | $32.62 | $34,805.54 |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · nonDerivative · entry 2 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,262 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:00 UTC |
Minnix LaneshaSVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 2,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-22-000019 · wf-form4_164513521164222.xml · nonDerivative · entry 1 Minnix Lanesha · CIK 0001708662 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionPerformance Rights · Derivative | 7,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · derivative · entry 7 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,441 Underlying: Common Stock · 7,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
GrantPerformance Rights · Derivative | 9,171 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · derivative · entry 6 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,611 Underlying: Common Stock · 9,171 shares Expires not disclosed F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F4 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
GrantRestricted Stock Units · Derivative | 9,171 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · derivative · entry 5 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,688 Underlying: Common Stock · 9,171 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F3 · balance_after: The total restricted stock units beneficially owned by Mr. Gillespie has been adjusted to eliminate an inadvertent overstatement of 3,880 restricted stock units that was incorrectly included the total number of number of derivative securities beneficially owned following a February 27, 2019 reported transaction and to reflect the actual number of restricted stock units held by Mr. Gillespie following the grant reported on this Form 4. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Tax withholdingCommon Stock | 735 | $32.62 | $23,975.70 |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · nonDerivative · entry 2 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,795 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:59 UTC |
Gillespie Keith E.SVP, Chief Sales Officer
|
Exercise / conversionCommon Stock | 2,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000030625-22-000016 · wf-form4_164513510077832.xml · nonDerivative · entry 1 Gillespie Keith E. · CIK 0001641570 · SVP, Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:58 UTC |
Morytko TamaraPresident, FPD
|
GrantPerformance Rights · Derivative | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000015 · wf-form4_164513507166994.xml · derivative · entry 4 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,990 Underlying: Common Stock · 10,700 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:58 UTC |
Morytko TamaraPresident, FPD
|
GrantRestricted Stock Units · Derivative | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000015 · wf-form4_164513507166994.xml · derivative · entry 3 Morytko Tamara · CIK 0001780203 · President, FPD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,630 Underlying: Common Stock · 10,700 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:57 UTC |
Wilson KirkPresident, FCD
|
Exercise / conversionPerformance Rights · Derivative | 7,760 | $0.00 | $0.00 |
DisclosureSEC source: 0000030625-22-000014 · wf-form4_164513503653760.xml · derivative · entry 7 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,101 Underlying: Common Stock · 7,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.